Sat.Nov 19, 2022 - Fri.Nov 25, 2022

article thumbnail

The next era of Greater Boston’s biotech boom

PharmaVoice

How Boston became the biotech capital of the U.S., and is now preparing for the next era of life sciences growth

101
101
article thumbnail

Dental Health Plays Vital Role in Cardiovascular Well-Being

Pharmacy Times

Research also focuses on connection between oral hygiene and other chronic diseases, neurological disorders, pulmonary infections.

127
127
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Clinical Trials Can Thrive in the Digital Era

PharmExec

The Digital Medicine Society (DiMe) CEO Jennifer Goldsack and Takeda’s Head of Digital Health Sciences, Data Sciences Institute Shoibal Datta describe the current landscape of digitized clinical trials and the decisions needed to fully utilize their potential.

86
article thumbnail

Dr Frank Mathias

Pharmafile

Dr Frank Mathias has been appointed as life science firm Oxford Biomedica’s new CEO. Dr Mathias will take on his new role in March 2023, when he will replace Dr Roch Doliveux. The firm focuses on cell and gene therapies.

80
article thumbnail

How bacteria-enabled technology for wounds could also help cancer patients

PharmaVoice

Evelina Vågesjö, co-founder and CEO of the immunotherapy company Ilya Pharma, is working on a new modality to speed wound healing

87
article thumbnail

Gabapentin Presents High Potential for Misuse

Pharmacy Times

Although the anticonvulsant is not considered a controlled substance, some state legislation focuses on monitoring the use of or reclassifying it.

article thumbnail

Tuning Into CTV - Real Time Data For Marketers

PharmExec

In episode 122, Marcella Milliet Sciorra, Chief Marketing Officer at DeepIntent, discusses Connected TV, or CTV, how it differs from over the top, and how CTV fits into the future of pharmaceutical marketing.

82

More Trending

article thumbnail

In cancers with very low survival rates, Sellas aims higher

PharmaVoice

The company hopes its drugs can “take over where other available treatments fail” in multiple types of cancer

87
article thumbnail

Workplace Stress Was Highest Among Younger Employees During COVID-19 Pandemic

Pharmacy Times

Study finds early career workers were more likely to disengage during the pandemic, such as by showing a lack of interest or becoming cynical about work.

118
118
article thumbnail

Exploring the “Other” End-User – HCPs and the Challenges to Adoption of Machine Learning-based Digital Solutions

PharmExec

Webinar Date/Time: Mon, Dec 5, 2022 2:00 PM EST. us

82
article thumbnail

FDA approves first gene therapy for Haemophilia B

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has approved Hemgenix (etranacogene dezaparvovec), the first gene therapy for adults with Haemophilia B (congenital Factor IX deficiency) who currently use Factor IX prophylaxis therapy, or have current or historical life-threatening haemorrhage, or have repeated, serious spontaneous bleeding episodes.

article thumbnail

Why the biopharma ‘IPO playbook’ changed in 2022

PharmaVoice

Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound

87
article thumbnail

Improve Pain Management With Precision Pharmacotherapy

Pharmacy Times

Leveraging pharmacogenomic testing, simultaneous multidrug analysis can help prevent drug interactions affecting pain management.

114
114
article thumbnail

Bottom of the Funnel Conversion though EHR Marketing and its Role in an Omnichannel Strategy

PharmExec

Webinar Date/Time: Wed, Dec 7, 2022 2:00 PM EST. us

82
article thumbnail

Taking the right forecasting approach for rare diseases

Pharma Phorum

There are approximately 7,000 different types of rare disease and researchers estimate that there are more than 300 million people worldwide living with such a condition, according to the National Institutes of Health (NIH).

article thumbnail

Sporting a $3.5M price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line

Fierce Pharma

Sporting a $3.5M price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line. zbecker. Wed, 11/23/2022 - 10:10

FDA 99
article thumbnail

Multiple SARS-CoV-2 Infections May Elevate Risk of Organ Failure, Death

Pharmacy Times

Individuals with COVID-19 reinfections were twice as likely to die and three times more likely to be hospitalized than those who did not have COVID-19 multiple times.

Hospitals 114
article thumbnail

Google rolls out search features that aim to make it easier to sign up for Medicaid, Medicare

Fierce Healthcare

Google rolls out search features that aim to make it easier to sign up for Medicaid, Medicare. pminemyer. Wed, 11/23/2022 - 11:12

98
article thumbnail

First-in-human gene therapy trial for major cardiac syndrome

European Pharmaceutical Review

The first-in-human gene therapy trial for heart failure patients with preserved ejection fraction (HFpEF) has been approved by the US Food & Drug Administration (FDA).

article thumbnail

On a roll, Takeda's dengue vaccine shifts into FDA's fast review lane

Fierce Pharma

On a roll, Takeda's dengue vaccine shifts into FDA's fast review lane. kdunleavy. Wed, 11/23/2022 - 09:35

article thumbnail

Kidney Damage From Diabetes Worsens Over Time

Pharmacy Times

Pharmacists play a significant role in the comprehensive management of this condition through education, intervention, and monitoring.

109
109
article thumbnail

Walgreens plots 'aggressive' strategy to build out healthcare services, CEO Roz Brewer says

Fierce Healthcare

Walgreens plots 'aggressive' strategy to build out healthcare services, CEO Roz Brewer says. hlandi. Sun, 11/20/2022 - 18:20

96
article thumbnail

Ex-Theranos CEO Elizabeth Holmes sentenced to 11 years

Pharma Phorum

Elizabeth Holmes, the founder and former chief executive of blood testing biotech Theranos, has been sentenced after being convicted of defrauding investors in the company earlier this year, receiving a prison sentence of more than 11 years in a California court.

FDA 95
article thumbnail

Senator aims to cut biosimilar 'red tape' with proposal to eliminate interchangeable status

Fierce Pharma

Senator aims to cut biosimilar 'red tape' with proposal to eliminate interchangeable status. kdunleavy. Wed, 11/23/2022 - 07:18

97
article thumbnail

Alzheimer Law Allows Younger Patients to Gain Eligibility for Grants, Programs

Pharmacy Times

Legislation expands protection of original 1965 act to individuals younger than 60 years.

109
109
article thumbnail

Iveda reveals AI-driven caregiver assistant, IvedaCare

Pharmafile

Iveda, a US-based technology company, has introduced their new cloud-based artificial intelligence (AI) assistant called IvedaCare. The company says they have designed the at-home AI caregiver for ‘safety, security, and elderly care.’. read more. Business Services

65
article thumbnail

Advocacy groups press FTC to probe GPOs' role in supply chain shortages

Fierce Healthcare

Advocacy groups press FTC to probe GPOs' role in supply chain shortages. rking. Tue, 11/22/2022 - 16:21

94
article thumbnail

J&J's nasal spray Spravato bests former AZ drug Seroquel XR in treatment-resistant depression trial

Fierce Pharma

J&J's nasal spray Spravato bests former AZ drug Seroquel XR in treatment-resistant depression trial. fkansteiner. Wed, 11/23/2022 - 09:26

96
article thumbnail

Locking Prescription Vials Helps Keep Medicine Safe in Medication-assisted Treatment Programs

Pharmacy Times

For patients with opioid use disorder, medication-assisted treatment programs are a clinically effective approach.

109
109
article thumbnail

Haemophilia drug costing $3.5m per dose has been approved

Pharmafile

CSL Behring’s haemophilia B gene therapy has recently been approved by US regulators, however the treatment has an enormous price tag. Costing $3.5m per dose, the one-off infusion therapy has become the world’s most expensive medicine currently available.

65
article thumbnail

Provention prices type 1 diabetes drug Tzield at $194,000

Pharma Phorum

Provention Bio has priced its new type 1 diabetes (T1D) prevention therapy Tzield at $13,850 per vial – equivalent to almost $194,000 for its 14-day course – a higher level than had been predicted by industry observers.

article thumbnail

Ozempic compensating for Wegovy’s supply shortage due to high demand

Pharmaceutical Technology

In recent months, Wegovy (semaglutide), indicated for obesity, has been subjected to widespread supply shortages due to high demand, in addition to manufacturer production problems, with Novo Nordisk intending to relaunch Wegovy by the end of 2022.

article thumbnail

5 Hot Topics for Community Pharmacists in 2023

Pharmacy Times

As a new year approaches, pharmacists have so much to look back on and be grateful for, and a world of opportunity in front of them. Here are a few things to be ready for right away in 2023.

109
109
article thumbnail

Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits

Fierce Pharma

Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits. fkansteiner. Wed, 11/23/2022 - 08:05

91
article thumbnail

Why should pharma invest in digital products for those living with rare diseases?

Pharma Phorum

Each person living with a rare disease has a unique experience of their condition, but all will have faced similar challenges.

article thumbnail

NICE questions value and efficacy of five Covid-19 drugs with rejection

Pharmaceutical Technology

The UK's National Institute for Health and Care Excellence (NICE) has published a draft guidance that does not recommend the use of five major Covid-19 therapies.

article thumbnail

New Tool Developed to Track How Breast Cancer Grows

Pharmacy Times

New system combines computational and experimental techniques to map evolutionary cancer lineages in their natural habitat of human tissue.

109
109